Saks, Nordstrom, Ma...
Health Care: Drugs
Sucampo Pharmaceuticals Inc. A (SCMP: NASDAQ)
$8.95 -0.55 | -5.79%
05/21/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | -774,139 | -730,483 | -771,744 | -573,980 | -271,478 | 313 | 0 |
| Shares Bought | 242 | 242 | 0 | 313 | 313 | 313 | 0 |
| Shares Sold | 774,381 | 730,725 | 771,744 | 574,293 | 271,791 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 36.68M | 36.41M | 36.57M | 36.75M | 11.46M | 11.43M | 11.29M |
| Shares Bought | 27.92M | 27.79M | 27.80M | 27.79M | 2.39M | 2.46M | 2.36M |
| Shares Sold | 629,374 | 668,032 | 637,226 | 723,724 | 4.87M | 4.88M | 4.88M |
Portfolios with SCMP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- UserGFNN Stockdiagnostics 5
- User©SUPRATRADE HOT STOCKS (...
Latest SCMP Headlines from TheStreet
- Sucampo Pharmaceuticals Inc. A Stock Downgraded (SCMP) 05.09.13 | 05:05 am
- 5 Stocks Under $10 Set to Soar 04.25.13 | 01:04 pm
- Sucampo Pharmaceuticals Inc. A Stock Upgraded (SCMP) 04.18.13 | 05:04 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- 5 Stocks Under $10 Triggering Breakouts 03.14.13 | 01:03 pm
- Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
- Sucampo Pharmaceuticals Inc. A Stock Downgraded (SCMP) 03.12.13 | 05:03 am
- Play TheStreet's FDA Drug Approval Contest 03.05.13 | 12:03 pm
- TheStreet Ratings Top 10 Rating Changes 01.14.13 | 10:01 am
- Sucampo Pharmaceuticals Inc. A Stock Upgraded (SCMP) 01.14.13 | 04:01 am
Press Releases for SCMP
- Sucampo Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2012 Financial And Operating Results - Business Wire 03.13.13 | 05:03 pm
- Sucampo Pharmaceuticals Announces Fourth Quarter And Full Year 2012 Financial Results And Operating Highlights Teleconference And Webcast - Business Wire 03.06.13 | 06:03 am
- Sucampo Appoints Barbara A. Munder And Maureen E. O’Connell To Board Of Directors - Business Wire 03.01.13 | 06:03 am
- Sucampo Announces Commercial Availability Of RESCULA In U.S. Pharmacies - Business Wire 02.19.13 | 08:02 pm
- Sucampo Files Patent Infringement Lawsuit Against Anchen Pharmaceuticals And Par Pharmaceuticals - Business Wire 02.08.13 | 06:02 am
- Sucampo Pharmaceuticals To Present At Investment Conferences - Business Wire 02.06.13 | 06:02 am
- Sucampo Announces Japanese Government Funding For Unoprostone Isopropyl Development In Retinitis Pigmentosa - Business Wire 02.04.13 | 06:02 am
- Sucampo Pharmaceuticals Announces Webcast Of Its Presentation At The Biotech ShowcaseTM 2013 Conference - Business Wire 01.03.13 | 06:01 am
- Sucampo Announces FDA Approval Of An SNDA For RESCULA® (unoprostone Isopropyl) - Business Wire 12.12.12 | 06:12 am
- Sucampo Receives $15 Million Milestone Payment From Abbott On First Sale Of AMITIZA® (lubiprostone) In Japan - Business Wire 12.11.12 | 06:12 am
Partner Headlines for SCMP
- 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year - Seeking Alpha 08.28.12 | 09:08 am
- Phase 3 Long-Term Safety Trial Results of Lubiprostone in Patients with Irritable Bowel Syndrome with Constipation was Recently Published in Alimentary Pharmacology and Therapeutics - Benzinga 03.06.12 | 04:03 pm
- Life Sciences Companies Raise Record Amounts of Capital - Seeking Alpha 12.31.10 | 04:12 pm
